Literature DB >> 8260714

Minor histocompatibility antigens HA-1-, -2-, and -4-, and HY-specific cytotoxic T-cell clones inhibit human hematopoietic progenitor cell growth by a mechanism that is dependent on direct cell-cell contact.

W A Marijt1, W F Veenhof, E Goulmy, R Willemze, J J van Rood, J H Falkenburg.   

Abstract

HLA-identical bone marrow transplantation (BMT) may be complicated by graft-versus-host disease or graft rejection. Both complications are thought to be initiated by recognition of minor histocompatibility (mH) antigens by HLA-restricted mH-antigen-specific T lymphocytes. Using HLA-A2-restricted mH antigens HA-1-, -2-, and -4-, and HY-specific cytotoxic T lymphocyte (CTL) clones, we studied the recognition by these CTL clones of interleukin-2 (IL-2)-stimulated T cells (IL-2 blasts), BM mononuclear cells (BMMNCs), and hematopoietic progenitor cells (HPCs). We showed that, when IL-2 blasts from the BM donors who were investigated were recognized by the HA-1-, -2-, and -4-, and HY-specific CTL clones, their BMMNCs and HPCs were recognized as well by these CTL clones, resulting in antigen-specific growth inhibition of erythrocyte burst-forming units (BFU-E), colony-forming units-granulocyte (CFU-G), and CFU-macrophage (CFU-M). the HA-2-specific CTL clone, however, inhibited BFU-E and CFU-G growth from four donors to a lesser extent than from two other donors. We further investigated whether inhibitory cytokines released into the culture medium by the antigen-specific stimulated CTLs or by stimulated BMMNCs were responsible for suppression of HPC growth or whether this effect was caused by direct cell-cell contact between CTLs and HPCs. HPC growth inhibition was only observed after preincubation of BMMNCs and CTLs together for 4 hours before plating the cells in semisolid HPC culture medium. When no cell-cell contact was permitted before plating, neither antigen-stimulated CTL nor antigen-nonstimulated CTLs provoked HPC growth inhibition. Culturing BMMNCs in the presence of supernatants harvested after incubation of BMMNCs and CTL clones together for 4 or 72 hours did also not result in HPC growth inhibition. Both suppression of HPC growth and lysis of IL-2 blasts and BMMNCs in the 51Cr-release assay appeared to be dependent on direct cell-cell contact between target cells and CTLs and were not caused by the release of inhibitory cytokines into the culture medium by antigen-specific stimulated CTLs or by stimulated BMMNCs. Our results show that mH-antigen-specific CTLs can inhibit HPC growth by a direct cytolytic effect and may therefore be responsible for BM graft rejection after HLA-identical BMT.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8260714

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  Evidence for ineffective erythropoiesis in severe sickle cell disease.

Authors:  Catherine J Wu; Lakshamanan Krishnamurti; Jeffery L Kutok; Melinda Biernacki; Shelby Rogers; Wandi Zhang; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2005-08-09       Impact factor: 22.113

2.  Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem cell transplants.

Authors:  Stephen Spellman; Melissa B Warden; Michael Haagenson; Bradley C Pietz; Els Goulmy; Edus H Warren; Tao Wang; Thomas M Ellis
Journal:  Biol Blood Marrow Transplant       Date:  2009-07       Impact factor: 5.742

3.  Suppression of haematopoiesis by IgG autoantibodies from patients with systemic lupus erythematosus (SLE).

Authors:  H Liu; K Ozaki; Y Matsuzaki; M Abe; M Kosaka; S Saito
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

4.  Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes.

Authors:  L M Faber; J van der Hoeven; E Goulmy; A L Hooftman-den Otter; S A van Luxemburg-Heijs; R Willemze; J H Falkenburg
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

5.  The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing.

Authors:  A G Brickner; E H Warren; J A Caldwell; Y Akatsuka; T N Golovina; A L Zarling; J Shabanowitz; L C Eisenlohr; D F Hunt; V H Engelhard; S R Riddell
Journal:  J Exp Med       Date:  2001-01-15       Impact factor: 14.307

6.  Possible role of minor h antigens in the persistence of donor chimerism after stem cell transplantation; relevance for sustained leukemia remission.

Authors:  Cornelis R van der Torren; Yvette van Hensbergen; Susanne Luther; Zohara Aghai; Zuzana Stachová Rychnavská; Manon Slot; Sicco Scherjon; Nicolaus Kröger; Arnold Ganser; Eva M Weissinger; Els Goulmy; Lothar Hambach
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.